Acute Coronary Syndrome

Type: Keyphrase
Name: Acute Coronary Syndrome
First reported 13 hours ago - Updated 11 hours ago - 1 reports

Smoking Pot Linked Once More to Heart Problems

(Newser)–Where there's smoke, there's usually fire—and when it comes to marijuana smoke, scientists are once again fanning the embers of a long-suspected theory that the drug is linked to cardiovascular issues. According to a case study published last ... [Published Newser - 13 hours ago]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

‘Strengthen Emergency Response‘

William Ofori, country manager of AstraZeneca, a multi-national pharmaceutical company, has asked government to put in place measures to upgrade the country’s poor medical emergency response system.He said increasing public knowledge of what to do during ... [Published Daily Guide Ghana - Oct 01 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 2 reports

New Evidence Marijuana Causes Heart Problems

Marijuana appears to have triggered a heart attack in a healthy 21-year-old British man, according to a new report of the case.The young man at was reportedly a regular marijuana and cigarette smoker, but went into cardiac arrest after smoking pot. Experts ... [Published NewsMax.com - Sep 30 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 2 reports

New Non-ST-Elevation ACS Guidelines: New Title, New Approach

DALLAS, TX and WASHINGTON, DC — The American Heart Association and the American College of Cardiology have issued a guideline for the management of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) [1] , which addresses the "landmark ... [Published General Medicine eJournal - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 11 reports

Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Summary GlobalData has released its new PharmaPoint Drug Evaluation report, "Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to... ... [Published Kait 8 - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Elderly woman (74) given blood thinners after radiologist failed to spot brain bleed

A pensioner was given blood thinners after a radiologist failed to spot a small bleed in her brain on a CT scan, an inquest heard. Dympna Halpin (74) from Killeary, Lobinstown in Navan, Co Meath, subsequently developed a massive bleed on the brain which ... [Published Irish Independent - Sep 29 2014]
First reported Sep 25 2014 - Updated Sep 26 2014 - 1 reports

Why heart attacks among Indian women are on the rise and what they need to do about it

While we are supporters of equality of women with men, certain parameters – on which women are fast catching up with men – are certainly emanating disturbing signals. One such parameter is the rising incidence of heart attack s among women. A disturbing ... [Published DNA India - Sep 25 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Making guidelines an ally

How avidly do clinicians follow guidelines? Perhaps only to the degree that their worth is apparent and appreciated.Guidelines came to the forefront this week, either with the release of new recommendations or the use of old ones. In one case, researchers ... [Published Cardiovascular Business - Sep 25 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Research and Markets: Acute Coronary Syndrome - Current and Future Players: Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GSK, Janssen Pharma, Merck, Pfizer & Sanofi

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ghvcj4/pharmapoint) has announced the addition of the "PharmaPoint: Acute Coronary Syndrome - Current and Future Players" report to their offering. The report is ... [Published Business Wire Health News - Sep 25 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 13 reports

Research and Markets: Anacetrapib Acute Coronary Syndrome Treatment Overview - Forecast and Market Analysis to 2023

Research and Markets ( http://www.researchandmarkets.com/research/txb949/anacetrapib ) has announced the addition of the "Anacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023" report to their offering.Click to Continue » ... [Published Fort Mills Times - Sep 25 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 27 reports

Research and Markets: Xarelto (rivaroxaban) for Acute Coronary Syndrome Report 2014 - Forecast and Market Analysis to 2023

Research and Markets ( http://www.researchandmarkets.com/research/q9t8mn/xarelto_acute ) has announced the addition of the "Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023" report to their offering.Click to Continue » ... [Published Fort Mills Times - Sep 24 2014]
First reported Sep 15 2014 - Updated Sep 16 2014 - 8 reports

Alirocumab Acute Coronary Syndrome Market Analysis & Forecasts to 2023

Dallas, TX -- (SBWIRE) -- 09/16/2014 -- “Zontivity (Acute Coronary Syndrome) Forecast and Market Analysis to 2023?. The current ACS market primarily comprised of antithrombotics, antihypertensives, and statins is flush with well-established standard-of-care ... [Published CEOWorld Magazine - Sep 16 2014]

Quotes

...month in the Journal of Emergency Medicine , a 21-year-old man who was a regular pot user suffered a heart attack—and doctors identified cannabis "as the most significant precipitant of his acute coronary syndrome" LiveScience reports. It's not the first time marijuana has been tied to heart problems...
"Although our patient was a cigarette smoker and had elevated lipid levels, cannabis use was identified as the most significant precipitant of his acute coronary syndrome,” the researchers wrote in the study."
...patients with this serious disease," stated Paul Rubin, M D , Senior Vice President, Research and Development, and Chief Medical Officer of XOMA. "It was important that the study design allows for the inclusion of patients experiencing active inflammatory episodes, as well as patients who are currently under control but may benefit from an alternative therapy."
"Although our patient was a cigarette smoker and had elevated lipid levels, cannabis use was identified as the most significant precipitant of his acute coronary syndrome,” (ACS) the researchers wrote in the study. (Acute coronary syndrome is a term used to describe symptoms related to the obstruction of the coronary arteries, which feed the heart muscle itself, which may occur as a result of a heart attack.)"

More Content

All (306) | News (245) | Reports (0) | Blogs (57) | Audio/Video (0) | Fact Sheets (2) | Press Releases (1)
sort by: Date | Relevance
Smoking Pot Linked Once More to Heart Problems [Published Newser - 13 hours ago]
ISAR-TRIPLE: Six-Week vs Six-Month Clopidogrel ... [Published Diabetes Care - 14 hours ago]
Strict Blood Sugar Control After Heart Surgery ... [Published theCSRfeed - 19 hours ago]
Strict Blood Sugar Control After Heart Surgery ... [Published Newswise - Oct 01 2014]
‘Strengthen Emergency Response‘ [Published Daily Guide Ghana - Oct 01 2014]
Neutrophil/Lymphocyte Ratio Is Associated with ... [Published Plosone.org - Sep 30 2014]
New Evidence Marijuana Causes Heart Problems [Published NewsMax.com - Sep 30 2014]
XOMA Initiates U.S. Clinical Trial of Gevokizum... [Published Scottrade - Sep 30 2014]
Hidden Risk? Marijuana May Be Bad for Your Heart [Published LiveScience.com - Sep 30 2014]
New Non-ST-Elevation ACS Guidelines: New Title,... [Published General Medicine eJournal - Sep 29 2014]
New Non-ST-Elevation ACS Guidelines: New Title,... [Published Medscape - Sep 29 2014]
Xarelto (Acute Coronary Syndrome) - Forecast an... [Published Kait 8 - Sep 29 2014]
Evacetrapib (Acute Coronary Syndrome) - Forecas... [Published Sacramento Bee - Sep 29 2014]
Bococizumab (Acute Coronary Syndrome) - Forecas... [Published Sacramento Bee - Sep 29 2014]
Evacetrapib (Acute Coronary Syndrome) - Forecas... [Published Indianapolis Business Journal - Sep 29 2014]
Xarelto (Acute Coronary Syndrome) - Forecast an... [Published Individual.com - Sep 29 2014]
Evacetrapib (Acute Coronary Syndrome) - Forecas... [Published Individual.com - Sep 29 2014]
Bococizumab (Acute Coronary Syndrome) - Forecas... [Published Individual.com - Sep 29 2014]
Bococizumab (Acute Coronary Syndrome) - Forecas... [Published PR Newswire - Sep 29 2014]
Evacetrapib (Acute Coronary Syndrome) - Forecas... [Published PR Newswire: Entertainment & Media - Sep 29 2014]
Xarelto (Acute Coronary Syndrome) - Forecast an... [Published PR Newswire: Entertainment & Media - Sep 29 2014]
Bococizumab (Acute Coronary Syndrome) - Forecas... [Published Scottrade - Sep 29 2014]
Elderly woman (74) given blood thinners after r... [Published Irish Independent - Sep 29 2014]
Xarelto Bleeding Lawsuit Contends Woman Almost ... [Published PRWeb - Sep 28 2014]
Ludhiana runs for Dil ki Daud' mini marathon [Published Business Standard India - Sep 28 2014]
Your heart is in your hands [Published The Gulf Today - Sep 26 2014]
Why heart attacks among Indian women are on the... [Published DNA India - Sep 25 2014]
Digoxin in AF and Leveraging the VA System for ... [Published Theheart.org - Sep 25 2014]
Regado Lays Off 60% of Workforce after Phase II... [Published Genetic Engineering News - Sep 25 2014]
Making guidelines an ally [Published Cardiovascular Business - Sep 25 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Strict Blood Sugar Control After Heart Surgery ... [Published theCSRfeed - 19 hours ago]
Study results may encourage hospitals to consider more liberal blood sugar control policies SOURCE: Elsevier DESCRIPTION: Chicago, October 1, 2014 /3BL Media/ – Patients undergoing coronary artery bypass grafting (CABG) surgery may not have to follow ...
Evacetrapib (Acute Coronary Syndrome) - Forecas... [Published PR Newswire: Entertainment & Media - Sep 29 2014]
NEW YORK, Sept. 29, 2014 /PRNewswire/ -- Evacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023SummaryGlobalData has released its new PharmaPoint Drug Evaluation report, "Evacetrapib (Acute Coronary Syndrome) - Forecast and Market ...
Xarelto (Acute Coronary Syndrome) - Forecast an... [Published PR Newswire: Entertainment & Media - Sep 29 2014]
   NEW YORK, Sept. 29, 2014 /PRNewswire/ -- Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023SummaryGlobalData has released its new PharmaPoint Drug Evaluation report, "Xarelto (Acute Coronary Syndrome) - Forecast and Market... ...
Research and Markets: Acute Coronary Syndrome -... [Published Business Wire Health News - Sep 25 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ghvcj4/pharmapoint) has announced the addition of the "PharmaPoint: Acute Coronary Syndrome - Current and Future Players" report to their offering. The report is ...
Research and Markets: Anacetrapib Acute Coronar... [Published Business Wire Professional Services News - Sep 25 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/txb949/anacetrapib) has announced the addition of the "Anacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023" report to their offering. The ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.